The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | V | Various | |
| 2 | V09 | Diagnostic radiopharmaceuticals | |
| 3 | V09I | Tumour detection | |
| 4 | V09IX | Other diagnostic radiopharmaceuticals for tumour detection | |
| 5 | V09IX16 |
| Active Ingredient | Description | |
|---|---|---|
| Piflufolastat ¹⁸F |
Piflufolastat (18F) is a selective secondgeneration fluorine-18-labeled small-molecule PSMA inhibitor. Based on the intensity of the signals, PET images obtained using piflufolastat (18F) indicate the presence of PSMA expressing tissues. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| PYLCLARI Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
